Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linsitinib + Bortezomib + Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT01672736Phase 2Terminated
- Sponsor
- University Health Network
- Start
- Sep 2012
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of linsitinib in multiple myeloma (MM), sponsored by University Health Network. Started Sep 2012; status: terminated.
02
Drugs
linsitinib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01672736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01672736.